Bayer Competitors and Similar CompaniesClear all
Bayer's competitors and similar companies include AstraZeneca, Roche, GSK and Johnson & Johnson.
 AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Johnson & Johnson Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field. | |||
Founding Date | Founding Date 1863 | Founding Date 1999 | Founding Date 1896 | Founding Date 2000 | Founding Date 1886 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations New Brunswick, US HQ Buenos Aires, AR Sydney, AU Vienna, AT Minsk, BY Beerse, BE Sofia, BG see more | ||
Employees | Employees 88,5021% decrease | Employees 94,300 | Employees 103,249 | Employees 68,629 | Employees 138,1005% increase |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 2.7 b | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) 396.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) $94.2b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods $4.9b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods $30.3b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit $54.2b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit $63.9b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income $10.2b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income £6.3b (FY, 2025) | Net income $26.8b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries 83 (FY, 2021) | Countries 130 (FY, 2021) | Countries N/A | Countries 92 (FY, 2021) | Countries N/A |
Suppliers | Suppliers 93.8 k (FY, 2021) | Suppliers N/A | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers N/A |
Funding | |||||
Total funding raised | Total funding raised $ 3.5b | Total funding raised $ 1b | Total funding raised $ 7.8b | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
AstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View companyJohnson & Johnson
HQ
New Brunswick, US
Employees
138,100↑ 5% increase
Johnson & Johnson (J&J) is a company that engages in the research and development, manufacture, and sale of a range of products in the healthcare field.
View company